单胺氧化酶A
癌症研究
前列腺癌
转移
生物
上皮-间质转换
癌变
蛋白激酶B
基因敲除
单胺氧化酶
癌症
医学
内科学
信号转导
细胞凋亡
细胞生物学
酶
生物化学
作者
Jason Boyang Wu,Chen Shao,Xiangyan Li,Qinlong Li,Peizhen Hu,Changhong Shi,Yang Li,Yi‐Ting Chen,Fei Yin,Chun‐Peng Liao,Bangyan L. Stiles,Haiyen E. Zhau,Jean Chen Shih,Leland W.K. Chung
摘要
Tumors from patients with high-grade aggressive prostate cancer (PCa) exhibit increased expression of monoamine oxidase A (MAOA), a mitochondrial enzyme that degrades monoamine neurotransmitters and dietary amines. Despite the association between MAOA and aggressive PCa, it is unclear how MAOA promotes PCa progression. Here, we found that MAOA functions to induce epithelial-to-mesenchymal transition (EMT) and stabilize the transcription factor HIF1α, which mediates hypoxia through an elevation of ROS, thus enhancing growth, invasiveness, and metastasis of PCa cells. Knockdown and overexpression of MAOA in human PCa cell lines indicated that MAOA induces EMT through activation of VEGF and its coreceptor neuropilin-1. MAOA-dependent activation of neuropilin-1 promoted AKT/FOXO1/TWIST1 signaling, allowing FOXO1 binding at the TWIST1 promoter. Importantly, the MAOA-dependent HIF1α/VEGF-A/FOXO1/TWIST1 pathway was activated in high-grade PCa specimens, and knockdown of MAOA reduced or even eliminated prostate tumor growth and metastasis in PCa xenograft mouse models. Pharmacological inhibition of MAOA activity also reduced PCa xenograft growth in mice. Moreover, high MAOA expression in PCa tissues correlated with worse clinical outcomes in PCa patients. These findings collectively characterize the contribution of MAOA in PCa pathogenesis and suggest that MAOA has potential as a therapeutic target in PCa.
科研通智能强力驱动
Strongly Powered by AbleSci AI